As activists parse the results of Tuesday’s vote to protect abortion rights in Ohio, Jamie Corley is already well on her way to putting a similar measure in front of Missouri voters next year.
Autolus eyes November for potential US approval of Tecartus rival
Autolus Therapeutics is expecting an FDA decision on Nov. 16 for obecabtagene autoleucel (obe-cel), its CAR-T hopeful that would rival Gilead’s Tecartus in adult acute